David J. Mauro - 02 May 2022 Form 4 Insider Report for Codiak BioSciences, Inc.

Role
Chief Medical Officer
Signature
/s/ Yalonda Howze, by Power of Attorney for David J. Mauro
Issuer symbol
N/A
Transactions as of
02 May 2022
Net transactions value
$0
Form type
4
Filing time
04 May 2022, 16:29:09 UTC
Previous filing
06 Oct 2021
Next filing
20 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDAKQ Stock Option (Right to Buy) Award $0 +200,000 $0.000000 200,000 02 May 2022 Common Stock 200,000 $3.26 Direct F1
transaction CDAKQ Restricted Stock Units Award $0 +20,000 $0.000000 20,000 02 May 2022 Common Stock 20,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on May 2, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 On May 2, 2022, the reporting person was granted 20,000 restricted stock units, with one-third vesting on May 2, 2023, and the remainder vesting in two equal yearly installments on each of the one-year anniversaries thereafter.